Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3871924 | The Journal of Urology | 2008 | 5 Pages |
Abstract
Tumor size at diagnosis is decreasing with time in patients with stage I renal cell carcinoma. These data likely underestimate the proportion of all enhancing renal masses diagnosed at a small size. Patients with small masses may be appropriate candidates for nephron sparing surgery, energy based ablative therapy or active surveillance. Better technologies are needed to determine the diagnosis and prognosis of small enhancing renal masses.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Matthew R. Cooperberg, Katherine Mallin, Jamie Ritchey, Jacqueline D. Villalta, Peter R. Carroll, Christopher J. Kane,